Category: Oncology/Hematology
Global Oncology/Hematology
-
2024 Global Forecast for Cancer Immunotherapy Drug Discovery Outsourcing Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... 50 countries. The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD ... Read More
-
2024 Global Forecast for Hematology Oncology Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More
-
Cancer Biomarkers Market by Profiling Technology (Omics, Imaging), Cancer (Lung, Breast, Leukemia, Melanoma, Colorectal), Product (Instruments, Consumables), Application (Diagnostics, R&D, Prognostics), Enduser, and Region - Global Forecast to 2029
... projected to reach USD 42.0 billion by 2029 from USD 24.5 billion in 2024, at a CAGR of 11.3% during the forecast period. Factors like the rapid improvements in technology propel market expansion. in the ... Read More
-
Global Multiple Myeloma Therapeutics Databank Market Report
... 2021 to 2029. Medication segment is expected to be the highest contributor to this market, with $8,265.9 Million in 2020, and is anticipated to reach $14,610.5 Million by 2029, registering a CAGR of 6.57%. Medication ... Read More
-
Global Cancer Supportive Care Drugs Databank Market Report
... 6.77% from 2021 to 2029. Bisphosphonates segment is expected to be the highest contributor to this market, with $3,463.6 Million in 2020, and is anticipated to reach $6,456.7 Million by 2029, registering a CAGR of ... Read More
-
Global Stomach Cancer Treatment Databank Market Report
... 2023 to 2031. Targeted Therapy segment is expected to be the highest contributor to this market, with $2,319.0 Million in 2022, and is anticipated to reach $5,613.5 Million by 2031, registering a CAGR of 10.38%. ... Read More
-
Global Next Generation Cancer Diagnostics Databank Market Report
... 8.47% from 2023 to 2031. Next-Generation Sequencing segment is expected to be the highest contributor to this market, with $4,346.5 Million in 2022, and is anticipated to reach $9,095.4 Million by 2031, registering a CAGR ... Read More
-
Global Anti-Cancer Drug Databank Market Report
... 2031. Targeted Therapy segment is expected to be the highest contributor to this market, with $43,423.4 Million in 2022, and is anticipated to reach $75,119.7 Million by 2031, registering a CAGR of 6.32%. Hormonal Therapy ... Read More
-
Global Cancer Diagnostics Databank Market Report
... 2031. Consumables segment is expected to be the highest contributor to this market, with $167,321.8 Million in 2022, and is anticipated to reach $261,623.1 Million by 2031, registering a CAGR of 5.13%. Instruments segment is ... Read More
-
Global Brain Cancer Diagnostics Databank Market Report
... 2023 to 2031. Imaging Test segment is expected to be the highest contributor to this market, with $694.7 Million in 2022, and is anticipated to reach $1,223.4 Million by 2031, registering a CAGR of 6.54%. ... Read More
-
Global Radiation Oncology Databank Market Report
... 2031. Internal Beam Radiation Therapy segment is expected to be the highest contributor to this market, with $5,909.9 Million in 2022, and is anticipated to reach $13,883.2 Million by 2031, registering a CAGR of 10.01%. ... Read More
-
Global Oncology NGS Databank Market Report
... 2031. Targeted Sequencing & Resequencing segment is expected to be the highest contributor to this market, with $242.5 Million in 2022, and is anticipated to reach $709.3 Million by 2031, registering a CAGR of 12.73%. ... Read More
-
Global Acute Myeloid Leukemia Therapeutics Databank Market Report
... 5.19% from 2023 to 2031. Targeted Therapy and Immunotherapy segment is expected to be the highest contributor to this market, with $5,909.9 Million in 2022, and is anticipated to reach $8,938.5 Million by 2031, registering ... Read More
-
Global Castrate-resistant Prostate Cancer Databank Market Report
... 2023 to 2031. Hormonal Therapy segment is expected to be the highest contributor to this market, with $7,227.4 Million in 2022, and is anticipated to reach $12,564.7 Million by 2031, registering a CAGR of 6.39%. ... Read More
-
Global Cancer Registry Software Databank Market Report
... from 2023 to 2031. Integrated segment is expected to be the highest contributor to this market, with $35.1 Million in 2022, and is anticipated to reach $42.9 Million by 2031, registering a CAGR of 2.28%. Read More
-
Global Liver Cancer Drugs Databank Market Report
... 2023 to 2031. Targeted Therapy segment is expected to be the highest contributor to this market, with $1,442.5 Million in 2022, and is anticipated to reach $4,029.6 Million by 2031, registering a CAGR of 12.16%. ... Read More
-
Chronic Lymphocytic Leukemia (CLL) - Global Clinical Trials Review, 2024
... scenario. This report provides top line data relating to the clinical trials on Chronic Lymphocytic Leukemia (CLL). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. ... Read More
-
Mycosis Fungoides - Global Clinical Trials Review, 2024
... data relating to the clinical trials on Mycosis Fungoides. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials ... Read More
-
Global Photomedicine Market Size Study & Forecast, by Technology (Lasers, Polychromatic Polarized Light, Full Spectrum Light, Dichroic Lamps, Light Emitting Diodes, Fluorescent Lamps) by Application (Dermatology, Pain Management, Oncology, Ophthalmology, Wound Healing, Dental Procedures, Aesthetics, Others) and Regional Analysis, 2023-2030
... Others) and Regional Analysis, 2023-2030 Global Photomedicine Market is valued at approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period ... Read More
-
Global Oligonucleotide Therapeutics Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
Hematology Market Size, Trends, Analysis, and Outlook By Product (Hematology Analyzers, Flow Cytometers, Coagulation Analyzers, Slide Stainers, Centrifuges, Hemoglobinometers, Others), By Reagent (Coagulation Reagents, Flow Cytometry Reagents, Immun-hematology Reagents, Others), By Application (Drug Testing, Auto-immune Diseases, Cancer, Diabetes Mellitus, Infectious Diseases, Others), By End-User (Hospitals, Clinical Testing Institutes, Patient Self-testing, Others), by Country, Segment, and Companies, 2024-2032
... Diseases, Cancer, Diabetes Mellitus, Infectious Diseases, Others), By End-User (Hospitals, Clinical Testing Institutes, Patient Self-testing, Others), by Country, Segment, and Companies, 2024-2032 The global Hematology market size is poised to register 5.8% growth from 2024 ... Read More
-
Minimal Residual Disease (MRD) Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technology (Flow Cytometry, Polymerase Chain Reaction, Next Generation Sequencing, Others), By Application (Leukemia, Lymphoma, Multiple Myeloma, Others), By End User (Hospitals & Specialty Clinics, Academic & Research Institutions, Clinical Laboratories, Others), By Region and Competition, 2019-2029F
... End User (Hospitals & Specialty Clinics, Academic & Research Institutions, Clinical Laboratories, Others), By Region and Competition, 2019-2029F Global Minimal Residual Disease (MRD) Testing Market was valued at USD 1.33 Billion in 2023 and is ... Read More
-
Me Too Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class (Beta Blockers, Antidepressants, Statins, Proton Pump Inhibitors, Benzodiazepines, Others), By Therapeutic Area (Oncology, Diabetes, Hepatitis C, Cardiovascular, Others), By Region and Competition, 2019-2029F
... By Region and Competition, 2019-2029F Global Me Too Drugs Market was valued at USD 364.81 Million in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 5.87% through ... Read More
-
Companion Diagnostic Tests in Oncology Market (Detection Technique: Protein Detection, DNA Detection, and Others; and Biomarker: EGFR, KRAS, HER2, BRAF V600E, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
... Diagnostic Tests in Oncology Market – Scope of Report TMR’s report on the global companion diagnostic tests in oncology market studies the past as well as the current growth trends and opportunities to gain valuable ... Read More
-
Global Soft Tissue Sarcoma Targeted Drugs Market Growth (Status and Outlook) 2024-2030
... it is expected to grow at a CAGR of % from 2024 to 2030. LPI (LP Information)' newest research report, the “Soft Tissue Sarcoma Targeted Drugs Industry Forecast” looks at past sales and reviews total ... Read More